• If you are wondering whether MetLife at around US$78.82 offers fair value or a margin of safety, this article explains what the current price might be indicating.
• The stock has returned 10.7% over the last 30 days, while the 1-year return is 3.8% and the 3-year return is 67.2%. These figures can influence how investors view both potential upside and risk.
• Recent coverage has highlighted MetLife's position as a major US insurance company. Investors have been focusing on how interest rate expectations and sector sentiment might influence life insurers and their investment portfolios. At the same time, ongoing discussions around regulatory capital and balance sheet resilience continue to shape how the market prices large insurers such as MetLife.
• MetLife currently holds a valuation score of 3 out of 6. The next step is to break down what different valuation approaches suggest about the stock today and how a broader framework at the end of the article can help you interpret those results more effectively.

Approach 1: MetLife Excess Returns Analysis

The Excess Returns model evaluates how much profit a company is expected to generate above the return that shareholders require, based on its equity cost, and then capitalizes those additional profits into an intrinsic value per share.

For MetLife, the model uses a book value of $41.69 per share and a stable earnings per share estimate of $9.21, sourced from weighted future Return on Equity estimates from 8 analysts. The average Return on Equity used in the model is 15.86%, compared with a cost of equity of $4.31 per share. That difference produces an estimated excess return of $4.89 per share. In addition, the model factors in a stable book value of $58.06 per share, based on weighted book value estimates from 6 analysts.

Combining these inputs, the Excess Returns model provides an intrinsic value estimate of about $183.78 per share. Compared with the recent share price around $78.82, this framework suggests MetLife is trading at roughly a 57.1% discount, indicating a wide margin between the model value and the market price.

Result: UNDERVALUED

Our Excess Returns analysis suggests MetLife is undervalued by 57.1%. Track this in your watchlist or portfolio, or discover 51 more high quality undervalued stocks.

Approach 2: MetLife Price vs Earnings

For a profitable company like MetLife, the P/E ratio is a useful way to relate what you pay for the stock to the earnings it currently generates. Investors usually expect a higher P/E when they see stronger earnings growth or lower perceived risk, and a lower P/E when growth expectations are more modest or risks feel higher.

MetLife trades on a P/E of 14.81x. This sits above the Insurance industry average of 11.18x and also above the peer group average of 13.20x, which might initially suggest a richer valuation compared with sector and peer benchmarks.

Simply Wall St’s Fair Ratio for MetLife is 14.91x. This is a proprietary estimate of what the P/E could reasonably be, given factors such as the company’s earnings profile, industry, profit margins, market cap and risk characteristics. Because it is tailored to MetLife’s own fundamentals instead of broad group averages, it can be more informative than a simple comparison with peers or the wider industry.

The Fair Ratio of 14.91x is very close to the current P/E of 14.81x, which points to the stock being priced at roughly a fair level on this metric.

Result: ABOUT RIGHT

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 18 top founder-led companies.

Upgrade Your Decision Making: Choose your MetLife Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives are that tool, because they let you attach a clear story about MetLife’s future revenue, earnings and margins to your own fair value estimate. You can then compare that fair value with the current price to decide whether the stock fits your plan, all within Simply Wall St’s Community page where millions of investors share perspectives that update automatically as new earnings or news arrive. One investor might lean toward a higher fair value closer to the US$102 analyst target by focusing on international growth and digital transformation. Another might anchor nearer the US$75 target if more concerned about interest rates, credit risk and technology execution. Both of those stories are translated into forecasts and fair values that move as fresh information comes in.

Do you think there's more to the story for MetLife? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.